I

InnoBio

Asia, Negeri Sembilan, Malaysia, Nilai

Description

INNOBIO is a world leader in the extraction and refinement of high-purity natural plant bio-active ingredients and specialty products.

Investor Profile

InnoBio has made 4 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (75%)
  • Private Equity (25%)

Country Focus

  • France (100%)

Industry Focus

  • Biotechnology
  • Medical
  • Pharmaceutical
  • Therapeutics
  • Biopharma
  • Health Care
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does InnoBio frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
Sofinnova Investments
North America, California, United States, Menlo Park
Co-Investments: 1
Co-Investments: 1
Cemag Invest
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Andera Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 3
Inserm Transfert Initiative
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Morningside Venture Investments
Asia, Shanghai, China, Shanghai
Co-Investments: 1
IRDI SORIDEC Gestion
Europe, Midi-Pyrenees, France, Toulouse
Co-Investments: 1
Bpifrance
Europe, Ile-de-France, France, Maisons-alfort
Co-Investments: 3
IXO Private Equity
Europe, Midi-Pyrenees, France, Toulouse
Co-Investments: 2

What are some of recent deals done by InnoBio?

ENYO Pharma

Lyon, Rhone-Alpes, France

ENYO Pharma is a biopharmaceutical company based in Lyon, France.

BiopharmaBiotechnologyMedical
Series BJun 4, 2018
Amount Raised: $46,800,485
Advicenne

Paris, Ile-de-France, France

Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from rare kidney diseases.

BiotechnologyMedicalPharmaceuticalTherapeutics
Private EquityMar 20, 2017
Amount Raised: $17,179,197
MedDay

Paris, Ile-de-France, France

MedDay is a biotechnology company developing new drugs targeting brain metabolism.

BiotechnologyMedicalPharmaceutical
Series BApr 8, 2016
Amount Raised: $38,500,000
GamaMabs Pharma

Toulouse, Midi-Pyrenees, France

GamaMabs Pharma is a clinical-stage immuno-oncology company that developes optimized therapeutic antibodies for the treatment of cancer.

BiotechnologyHealth CareOncologyTherapeutics
Series BDec 15, 2015
Amount Raised: $16,393,693